Key Financial Figures - Quarter Ended September 30, 2026

  • Revenue from operations: ₹1,951.01 crore (compared to ₹1,757.15 crore in Q2 FY26)
  • Other income: ₹68.06 crore
  • Total income: ₹2,019.07 crore
  • Profit before tax: ₹610.47 crore (compared to ₹545.93 crore in Q2 FY26)
  • Total tax expenses: ₹157.02 crore
  • Profit for the period: ₹428.52 crore (compared to ₹415.27 crore in Q2 FY26)
  • Earnings per share (basic/diluted): ₹213.39 (not annualized)

Key Financial Figures - Half Year Ended September 30, 2026

  • Revenue from operations: ₹3,764.69 crore (compared to ₹3,495.50 crore in H1 FY26)
  • Other income: ₹143.43 crore
  • Total income: ₹3,908.12 crore
  • Profit before tax: ₹1,182.68 crore (compared to ₹1,039.06 crore in H1 FY26)
  • Total tax expenses: ₹300.71 crore
  • Profit for the period: ₹881.97 crore (compared to ₹781.13 crore in H1 FY26)
  • Earnings per share (basic/diluted): ₹415.04 (not annualized)

Expense Breakdown - Quarter Ended September 30, 2026

  • Cost of materials consumed: ₹183.34 crore
  • Purchases of stock-in-trade: ₹835.62 crore
  • Changes in inventories: (₹9.05) crore
  • Employee benefits expense: ₹175.24 crore
  • Finance costs: ₹5.91 crore
  • Depreciation and amortization: ₹5.95 crore
  • Other expenses: ₹192.85 crore
  • Total expenses: ₹1,408.60 crore

Tax Details - Quarter Ended September 30, 2026

  • Current tax expense: ₹154.88 crore
  • Tax adjustment for earlier years: (₹6.04) crore
  • Deferred tax expense/(credit): (₹3.18) crore

Cash Flow Statement - Half Year Ended September 30, 2026

  • Cash generated from operations: ₹949.22 crore
  • Income tax paid (including TDS): (₹290.25) crore
  • Net cash from operating activities: ₹658.97 crore
  • Purchase of property, plant and equipment: (₹15.05) crore
  • Investment in fixed deposits (>3 months): (₹1,195.99) crore
  • Redemption of fixed deposits: ₹2,296.12 crore
  • Interest received on deposits: ₹73.97 crore
  • Net cash from investing activities: ₹1,159.19 crore
  • Dividend paid: (₹1,393.95) crore
  • Principal payment of lease liabilities: (₹19.68) crore
  • Interest payment of lease liabilities: (₹8.04) crore
  • Net cash used in financing activities: (₹1,423.05) crore
  • Net increase in cash and cash equivalents: ₹395.11 crore
  • Cash and cash equivalents at beginning: ₹442.33 crore
  • Cash and cash equivalents at end: ₹837.44 crore

Capital Structure

  • Paid-up equity share capital: ₹21.25 crore (Face Value of ₹10 per equity share)
  • Other equity: ₹4,752.90 crore

Additional Information

  • The financial results were reviewed and recommended by the Audit Committee before Board approval
  • Prepared in accordance with Indian Accounting Standard 34 (Ind AS 34)
  • Company has only one segment: 'Pharmaceuticals'
  • Limited review conducted by statutory auditors Walker Chandiok & Co LLP
  • Limited review report contains no qualifications
  • Previous period figures have been regrouped/reclassified where necessary